Exemestane May Be Another First-Line, Adjuvant Therapy For Hormone-Receptor Positive,
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer...